ACQUITY UPLC I-Class / Xevo TQD IVD System
The rugged, robust and reliable Xevo TQD – a solid performer for clinical analyses
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
User friendly instrument and software
Metabolites quantitation
Hardware and software is user friendly, and instrument worked without any issues.
Review Date: 26 Mar 2024 | Waters
The single vendor solution for routine quantitative LC-MS/MS applications, providing maximum accessibility to the sensitivity, selectivity and robustness needed to ensure maximum productivity with minimum effort.
- Maximum uptime through unparalleled robustness
- Accelerated method development for sensitive and robust methods
- Reduces complexity and increases ease of use
- Maximum throughput and maximum uptime through unparalleled robustness
- The widest range of ionization capabilities today, future-proofing for the innovations of tomorrow
- Clinical laboratories now have access to the selectivity, sensitivity, and versatility of LC-MS/MS analysis not seen using traditional techniques
- Waters follows international quality standards with respect to its medical devices
ACQUITY UPLC I-Class/Xevo TQ-XS IVD System: Analytical performance for a mineralocorticoid
In this technical note, Waters describes a test of the analytical performance of the ACQUITY UPLC I-Class/Xevo TQ-XS IVD System for the analysis of aldosterone in plasma.
ACQUITY UPLC I-Class/Xevo TQD IVD System: Analytical performance for antiepileptic drugs
The Waters ACQUITY UPLC I-Class/Xevo TQD IVD System enables the quantification of organic compounds in human biological liquid matrices. In this application note, Waters describes a test of the analytical performance of the ACQUITY UPLC I-Class/Xevo TQD IVD system for the analysis of 10,11-dihydro-10-hydroxycarbamazepine, carbamazepine, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital, phenytoin, pregabalin, primidone, retigabine, tiagabine, topiramate, valproic acid, and zonisamide in plasma. Here, the Waters ACQUITY UPLC I-Class/Xevo TQD IVD System has demonstrated the capability to deliver an analytically sensitive and precise method for the analysis of antiepileptic drugs in plasma.
ACQUITY UPLC I-Class/Xevo TQD IVD System: Analytical performance for an alkylating agent
The ACQUITY™ UPLC™ I-Class/Xevo™ TQD IVD System developed by Waters provides the capability to precisely measure the amount of organic compounds present in human biological liquid matrices. In this application note, the analytical performance of the ACQUITY UPLC I-Class/Xevo TQD IVD System was tested for the quantitative analysis of busulfan present in plasma. The evaluation test measures the system's ability to accurately and consistently quantify busulfan in plasma samples.
